OptiBiotix Health (LSE:OPTI) EBITDA Margin %: -261.41% (As of Dec. 2025)


What is OptiBiotix Health EBITDA Margin %?

OptiBiotix Health LSE:OPTI EBITDA Margin % is -261.41% as of Dec. 2025. The stock has 4 warning signs investors should review. Among 944 Biotechnology companies, OptiBiotix Health ranks worse than 64.19% on this metric.

EBITDA Margin % is calculated as EBITDA divided by its Revenue. OptiBiotix Health's EBITDA for the six months ended in Dec. 2025 was £-1.59 Mil. OptiBiotix Health's Revenue for the six months ended in Dec. 2025 was £0.61 Mil. Therefore, OptiBiotix Health's EBITDA margin for the quarter that ended in Dec. 2025 was -261.41%.

OptiBiotix Health  (LSE:OPTI) EBITDA Margin % Explanation

EBITDA Margin % is the ratio of EBITDA divided by net sales or Revenue. It is an performance metric measuring company's operating profitability. EBITDA Margin takes depreciation and amortization, interest expense and tax into account, which makes it easy to compare the relative profitability of companies of different sizes in the same industry.

OptiBiotix Health EBITDA Margin % Related Terms

OptiBiotix Health EBITDA Margin % Historical Data

* Premium members only.

The historical data trend for OptiBiotix Health's EBITDA Margin % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

OptiBiotix Health EBITDA Margin % Chart

OptiBiotix Health Annual Data
Trend Nov15 Nov16 Nov17 Nov18 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
EBITDA Margin %
Get a 7-Day Free Trial Premium Member Only Premium Member Only 294.31 583.15 -231.52 -236.44 -251.03

OptiBiotix Health Semi-Annual Data
Nov15 May16 Nov16 May17 Nov17 May18 Nov18 May19 Jun20 Dec20 Jun21 Dec21 Jun22 Dec22 Jun23 Dec23 Jun24 Dec24 Jun25 Dec25
EBITDA Margin % Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -280.89 -347.83 -184.68 -239.68 -261.41

LSE:OPTI vs VRTX, REGN, ALNY: EBITDA Margin % Comparison

For the Biotechnology subindustry, OptiBiotix Health's EBITDA Margin %, along with its competitors' market caps and EBITDA Margin % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

OptiBiotix Health EBITDA Margin % vs Biotechnology Industry

For the Biotechnology industry and Healthcare sector, OptiBiotix Health's EBITDA Margin % distribution charts can be found below:

* The bar in red indicates where OptiBiotix Health's EBITDA Margin % falls into.


OptiBiotix Health EBITDA Margin % Calculation

EBITDA margin is the ratio of EBITDA divided by net sales or Revenue, usually presented in percent.

OptiBiotix Health's EBITDA Margin % for the fiscal year that ended in Dec. 2025 is calculated as

EBITDA Margin %=EBITDA (A: Dec. 2025 )/Revenue (A: Dec. 2025 )
=-2.927/1.166
=-251.03 %

OptiBiotix Health's EBITDA Margin % for the quarter that ended in Dec. 2025 is calculated as

EBITDA Margin %=EBITDA (Q: Dec. 2025 )/Revenue (Q: Dec. 2025 )
=-1.592/0.609
=-261.41 %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about EBITDA Margin % →
What does a EBITDA Margin % of -261.41% mean?
OptiBiotix Health (LSE:OPTI) has a EBITDA Margin % of -261.41% as of Dec. 2025. EBITDA Margin is the ratio of EBITDA divided by net sales or Revenue, usually presented in percent. View historical data on OptiBiotix Health and its competitors. According to the industry distribution chart, OptiBiotix Health ranks #606 out of 944 companies in the Biotechnology industry, placing it in the top 64.2%.
Is OptiBiotix Health's EBITDA Margin % too high?
OptiBiotix Health's current EBITDA Margin % is -261.41%. Based on the distribution chart, OptiBiotix Health ranks #606 out of 944 companies in the Biotechnology industry, which is below the industry midpoint.
How does OptiBiotix Health's EBITDA Margin % compare to VRTX and REGN?
According to the Biotechnology industry distribution chart, OptiBiotix Health ranks #606 out of 944 companies for EBITDA Margin %. This places OptiBiotix Health in the lower half of its industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good EBITDA Margin % for a Biotechnology company?
A good EBITDA Margin % depends on the Biotechnology industry context. However, EBITDA Margin % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high EBITDA Margin % mean?
A high EBITDA Margin % can signal that a stock is expensive relative to its fundamentals. EBITDA Margin is the ratio of EBITDA divided by net sales or Revenue, usually presented in percent. View historical data on OptiBiotix Health and its competitors. OptiBiotix Health's current EBITDA Margin % is -261.41%. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is OptiBiotix Health stock overvalued right now?
Based on GuruFocus' analysis, OptiBiotix Health (LSE:OPTI) is currently considered Possible Value Trap. The stock's GF Value™ is £0.30, compared to a current price of £0.06 — trading 78.8% below its estimated fair value. The current EBITDA Margin % is -261.41%. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is EBITDA Margin % calculated?
EBITDA Margin % is calculated from a company's financial statements. For OptiBiotix Health (LSE:OPTI), the current EBITDA Margin % is -261.41% as of Dec. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

OptiBiotix Health Business Description

Address Innovation Centre, Innovation Way, Heslington, York, GBR, YO10 5DG
OptiBiotix Health PLC principal activity is that of identifying and developing microbial strains, compounds, and formulations for use in food ingredients, supplements and active compounds that can impact on human physiology, deriving potential health benefits. It is a life sciences business focused on the development of products which reduce hunger and food cravings, enhance the gut microbiome, and provide a healthy substitute for sugar. Its product portfolio includes First-generation products- SlimBiome, WellBiome; and Second-generation solutions- SweetBiotix, Microbiome Modulators. The group has one class of business. It has presence in United Kingdom, United States, India China, and Rest of world. The company generates majority of revenue from United States.